“…- Age at HSCT or at time of PFT was available for all but 4/17 cohorts [ 45 , 49 , 51 , 53 ].
- 12/17 studies provided number of subjects with pulmonary cGVHD [ 42 , 44 – 46 , 48 , 49 , 52 , 54 – 58 ], whilst only eight studies provided number of subjects with extrapulmonary cGVHD [ 42 , 44 , 48 , 52 , 54 , 55 , 57 , 58 ].
- Among those studies reporting pulmonary cGVHD status, 4/17 (24%) did not provide the definition used [ 45 , 49 , 56 , 58 ], four used NIH criteria available at the time [ 42 , 48 , 54 , 57 ] and four used a modification of NIH criteria by adding criteria relating to presence of respiratory symptoms or cGVHD in other organ systems [ 44 , 52 , 55 ].
…”